ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

BCTXW BriaCell Therapeutics Corporation

0,1017
-0,0181 (-15,11%)
Après les heures de négociation
Dernière mise à jour : 22:00:01
Retardé de 15 minutes

Période:

Mode Dessin:

Volume 11 886
Prix Achat 0,1002
Prix Vente 0,128
Actualités -
Nom Action Symbole Action Marché Type
BriaCell Therapeutics Corporation BCTXW NASDAQ Warrant
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,0181 -15,11% 0,1017 22:00:01
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,1017 0,1017 0,1017 0,1017 0,1198
Transactions Totales Volume échangé VWAP Volume Financier Volume en moyenne
6 11 886  0,1016999  1 209 -
Dernière Transaction Type Quantités échangées Prix transaction Devise
22:00:00 1 300  0,1017 USD

Bilan Comptable

Capitalisation Boursière Actions en Circulation Float Chiffre d'affaires Bénéfice/Perte BPA Ratio Cours sur Bénéfices
2,19M 18,28M - 0 -4,79M -0,26 -
Short Interest Dividendes Par Action Rendement du Dividende Ex-Div Date Insider B/S Insider % Owned
- - - -

plus d’informations financières »

Actualités BriaCell Therapeutics

Date Heure Source Titre
06/2/202522:30Edgar (US Regulatory)Form 8-K - Current report
06/2/202500:15GlobeNewswire Inc.BriaCell Therapeutics Corp. Announces Results of Shareholder..
05/2/202523:02Edgar (US Regulatory)Form 8-K - Current report
05/2/202522:05GlobeNewswire Inc.BriaCell Therapeutics Announces Closing of Public Offering
04/2/202522:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
04/2/202501:59GlobeNewswire Inc.BriaCell Therapeutics Announces Pricing of Public Offering
03/2/202522:45GlobeNewswire Inc.BriaCell Therapeutics Announces Proposed Public Offering of..
03/2/202522:37Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
03/2/202513:30GlobeNewswire Inc.BriaCell Announces Resolution of Lung Metastasis in First..
28/1/202522:00Edgar (US Regulatory)Form 8-K - Current report
28/1/202500:42GlobeNewswire Inc.BriaCell Announces Completion of 15:1 Share Consolidation
17/12/202422:05GlobeNewswire Inc.BriaCell Announces Availability of Annual General Meeting..

Forum BriaCell Therapeutics

Aucune Discussion TrouvéeAjouter une Discussion

Historiques

Période Ouver. Haut Bas VWAP Moyenne Vol. Quot. Variation %
1 semaine0,000,000,000,0000,000,00%
1 mois0,000,000,000,0000,000,00%
3 mois0,000,000,000,0000,000,00%
6 mois0,000,000,000,0000,000,00%
1 an0,000,000,000,0000,000,00%
3 ans0,000,000,000,0000,000,00%
5 ans0,000,000,000,0000,000,00%

NASDAQ:BCTXW -

What is the current BriaCell Therapeutics Corporation share price?
The current share price of BriaCell Therapeutics Corporation is US$ 0,1017
How many BriaCell Therapeutics Corporation shares are in issue?
BriaCell Therapeutics Corporation has 18 284 000 shares in issue
What is the market cap of BriaCell Therapeutics Corporation?
The market capitalisation of BriaCell Therapeutics Corporation is USD 2,19M
What is the 1 year trading range for BriaCell Therapeutics Corporation share price?
BriaCell Therapeutics Corporation has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of BriaCell Therapeutics Corporation?
The price to earnings ratio of BriaCell Therapeutics Corporation is -40,44
What is the reporting currency for BriaCell Therapeutics Corporation?
BriaCell Therapeutics Corporation reports financial results in USD
What is the latest annual profit for BriaCell Therapeutics Corporation?
The latest annual profit of BriaCell Therapeutics Corporation is USD -4,79M
What is the registered address of BriaCell Therapeutics Corporation?
The registered address for BriaCell Therapeutics Corporation is SUITE 300 - 235 WEST 15TH STREET, VANCOUVER, BRITISH COLUMBIA, V7T 2X1
What is the BriaCell Therapeutics Corporation website address?
The website address for BriaCell Therapeutics Corporation is www.briacell.com
Which industry sector does BriaCell Therapeutics Corporation operate in?
BriaCell Therapeutics Corporation operates in the BUSINESS SERVICES, NEC sector

Dernières Valeurs Consultées

Delayed Upgrade Clock